Freya Biosciences ApS: Financial statements 2023
CVR: 41257547
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Freya Biosciences ApS (CVR 41257547) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -5,366,000 and a net result of DKK -81,096,000 compared with DKK -32,157,000 the year before. Equity in the 2023 report amounted to DKK 75,005,000. The solvency ratio was 91.7%. The company had 14 employees in the financial year.
- Gross Profit
- DKK -5,366,000
- Profit/Loss
- DKK -81,096,000
- Equity
- DKK 75,005,000
- Total Assets
- DKK 81,766,000
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -5.4 mio. | -81.1 mio. | 75 mio. | 14 |
| 2022 | - | -16.6 mio. | -32.2 mio. | -3.7 mio. | - |
| 2021 | 0 | -5.5 mio. | -20.4 mio. | 28.4 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of August 31, 2023, Randi Rich has stepped down as director of Freya Biosciences ApS.
Freya Biosciences ApS has published its annual report for 2022. Gross profit came to DKK -16,628,000, and the net result was DKK -32,157,000.
As of February 20, 2023, Claudia Maria Colciago has joined the board of directors of Freya Biosciences ApS.
As of February 20, 2023, is registered as an owner of Freya Biosciences ApS with an ownership share of 5%.
As of February 7, 2023, Randi Rich is registered as director of Freya Biosciences ApS.
About Freya Biosciences ApS
Freya Biosciences ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Colleen Denise Acosta. The board consists of Peter Finsel Bisgaard (chair), Claudia Maria Colciago, Colleen Denise Acosta and David Lawrence Stern. The company's owners include Danmarks Eksport- og Investeringsfond, OMX Ventures Fund I, LLC and Sofinnova Capital IX. The company has 18 employees (2026). In 2025, the company reported a gross profit of DKK -14,130,000 and a net result of DKK -92,714,000 compared with DKK -85,434,294 the year before. Equity in the 2025 report amounted to DKK 72,025,000.